N-ras mutation in poorly differentiated thyroid carcinomas: correlation with bone metastases and inverse correlation...

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Thyroid carcinomas exhibit diverse genetic alterations.
• The N-ras proto-oncogene is implicated in various cancers.
• Understanding N-ras mutations in thyroid cancer progression is crucial.

Purpose of the Study:

• To investigate the prevalence of N-ras oncogene mutations at codon 61 in thyroid carcinomas.
• To correlate N-ras mutations with different histological subtypes and differentiation status of thyroid tumors.
• To examine the relationship between N-ras mutations and thyroglobulin expression.

Main Methods:

• Utilized a polymerase chain reaction-primer introduced restriction with enrichment of mutant alleles (PCR-PIREMA) method.
• Screened codon 61 of the N-ras oncogene in 99 surgically resected thyroid carcinomas.
• Assessed thyroglobulin expression using immunohistochemical analysis.

Main Results:

• N-ras mutations were detected in 16.2% (16/99) of thyroid carcinomas.
• Mutations were observed in papillary (10%), follicular (40%), poorly differentiated (18.2%), and undifferentiated (60%) carcinomas.
• N-ras mutations were exclusively found in tumors with low or absent thyroglobulin expression, suggesting association with dedifferentiation.

Conclusions:

• N-ras codon 61 mutations are present in a subset of thyroid carcinomas, particularly in poorly and undifferentiated types.
• The presence of N-ras mutations correlates with reduced thyroglobulin expression, a marker of dedifferentiation.
• N-ras activation may play a role in the progression and dedifferentiation of thyroid tumors.